SOPHiA GENETICS (SOPH) Total Debt (2020 - 2026)

SOPHiA GENETICS (SOPH) posted Total Debt of $47.7 million for Q4 2025, little changed sequentially from $47.6 million in Q3 2025, and up 260.6% YoY from $13.2 million in Q4 2024.

SOPHiA GENETICS (SOPH) Total Debt (2020 - 2026) Analysis & Trends

SOPHiA GENETICS has reported Total Debt for 3 years, with the latest figure at $47.7 million in Q4 2025.

  • Quarterly Total Debt rose 260.6% year-over-year to $47.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $47.7 million (up 260.6% YoY) and the FY2025 annual result came in at $47.7 million, up 260.6% from the prior year.
  • Total Debt held at $47.7 million in Q4 2025 per SOPH's latest filing, from $47.6 million in the prior quarter.
  • Over five years, Total Debt peaked at $47.7 million in Q4 2025 and troughed at $13.2 million in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Veeva Systems 39.72 Bn 32.40 Bn 662.02 Mn -
2 BrightSpring Health Services 12.19 Bn 11.64 Bn 492.75 Mn 2.19 Bn
3 Healthequity 8.79 Bn 8.52 Bn 256.31 Mn 942.66 Mn
4 10x Genomics 7.31 Bn 6.76 Bn 112.50 Mn -
5 Hinge Health 7.10 Bn 6.71 Bn 183.95 Mn -
6 MiniMed 5.66 Bn 5.36 Bn 480.00 Mn -
7 Waystar Holding 4.76 Bn 4.56 Bn 221.99 Mn 1.47 Bn
8 Doximity 4.46 Bn 3.77 Bn 132.93 Mn -
9 Heartflow 3.66 Bn 3.28 Bn 53.19 Mn -
10 SOPHiA GENETICS 553.79 Mn 446.12 Mn - 48.00 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 48.00 Mn
Dec 31, 2025 47.73 Mn
Sep 30, 2025 47.58 Mn
Jun 30, 2025 47.47 Mn
Mar 31, 2025 13.32 Mn
Dec 31, 2024 13.24 Mn
Sep 30, 2024 13.16 Mn
Jun 30, 2024 13.34 Mn
Dec 31, 2020 3.33 Mn